Safety, Tolerability, and Pharmacokinetics of BGB-23339 in Healthy Japanese and Caucasian Subjects

Clinical trial NCT05387668 · WITHDRAWN

Trial details

NCT number: NCT05387668
Sponsor: BeiGene
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2022-02-17
Primary completion: 2022-10-17
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.